A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal Failure

Completed

Conditions studied: Chronic Renal Failure

In brief

We hope to study components within the blood that may predict success, failure or other associated complications in relation to the type of vascular access being used.

Key facts

Study ID

NCT00565994

Run by

University of Oklahoma

People needed

60

Starts

2008-01-01

Expected to finish

2010-09-01

Last updated by the study team

2010-09-28

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male and female patients of Dr. William Jennings and Dr. Pranay Kathuria undergoing dialysis therapy as outpatients
• Male and female patients of Dr. Pranay Kathuria who have been diagnosed with Stage 3, 4, or 5 chronic kidney disease, but who are not yet on dialysis.
• Healthy volunteers with no kidney disease, autoimmune disorders, recent (<6 months) chemotherapy treatment or corticosteroid use, or other chronic condition determined by the investigator to interfere with cytokine and inflammatory markers.
• 18 to 90 years of age

You may not qualify if…

• under 18 years of age
• over 90 years of age
• prisoners
• institutionalized patients
• pregnant individuals
• patients with mental illness who are not able to give informed consent

Where it is running

• University of Oklahoma-Tulsa — Tulsa, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.